Sandoz Takes Enbrel Fight To The US Supreme Court

Federal Circuit Decisions Last Year Leave Potential Eight-Year Wait On Etanercept

US-Supreme-Court_V1_1200
Sandoz is seeking US Supreme Court Review of the Fed. Cir.'s 1 July 2020 decision. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products